Understanding vaccine-elicited protective immunity against pre-erythrocytic stage malaria in endemic regions.
Correlates of protection
Data science
Immunology
Malaria
Systems vaccinology
Vaccine
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
received:
20
04
2020
revised:
26
08
2020
accepted:
24
09
2020
pubmed:
20
10
2020
medline:
18
3
2021
entrez:
19
10
2020
Statut:
ppublish
Résumé
Recent malaria vaccine trials in endemic areas have yielded disparate results compared to studies conducted in non-endemic areas. A workshop was organized to discuss the differential pre-erythrocytic stage malaria vaccine (Pre-E-Vac) efficacies and underlying protective immunity under various conditions. It was concluded that many factors, including vaccine technology platforms, host genetics or physiologic conditions, and parasite and mosquito vector variations, may all contribute to Pre-E-Vac efficacy. Cross-disciplinary approaches are needed to decipher the multi-dimensional variables that contribute to the observed vaccine hypo-responsiveness. The malaria vaccine community has an opportunity to leverage recent advances in immunology, systems vaccinology, and high dimensionality data science methodologies to generate new clinical datasets with unprecedented levels of functional resolution as well as capitalize on existing datasets for comprehensive and aggregate analyses. These approaches would help to unlock our understanding of Pre-E-Vac immunology and to translate new candidates from the laboratory to the field more predictably.
Identifiants
pubmed: 33071001
pii: S0264-410X(20)31253-6
doi: 10.1016/j.vaccine.2020.09.071
pii:
doi:
Substances chimiques
Malaria Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7569-7577Informations de copyright
Copyright © 2020.